MINI FUTURE LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Real-time Bid/Ask 04:09:01 2024-06-05 am EDT | ||
| 2.4 EUR / 2.41 EUR | +2.34% |
|
| Current month | +0.42% | ||
| 1 month | -7.39% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 24-06-04 | 2.35 | 0.00% |
| 24-06-03 | 2.35 | -0.84% |
| 24-05-31 | 2.37 | +2.60% |
| 24-05-30 | 2.31 | +0.43% |
| 24-05-29 | 2.3 | -3.77% |
Delayed Quote Börse Stuttgart
Last update June 04, 2024 at 03:02 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | Morgan Stanley |
| WKN | MB1XNT |
| ISIN | DE000MB1XNT5 |
| Date issued | 2023-01-02 |
| Strike | 24.62 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.59 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.85 € |
|---|---|
| Lowest since issue | 1.41 € |
| Spread | 0.01 € |
| Spread % | 0.41% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.2
EUR
Average target price
52.64
EUR
Spread / Average Target
+9.21%
- Stock Market
- Certificates
- Certificat
